Why the study?
Does alinidine maintain cardiac output by increasing stroke volume during controlled hypotension with sodium nitroprusside in patients under neuroleptanaesthesia?
Does alinidine maintain cardiac output by increasing stroke volume during controlled hypotension with sodium nitroprusside in patients under neuroleptanaesthesia?
Tachycardia is not essential for maintaining adequate cardiac output during controlled hypotension with sodium nitroprusside, as stroke volume increases compensatorily when heart rate is lowered.
May support stroke volume compensation during nitroprusside hypotension; hypothesis-generating for bradycardic agents in anesthesia, needs prospective confirmation.
The effects of N-allyl clonidine (St 567, alinidine), (0.5 mg/kg i.v.) a substance with specific bradycardic action at the sinus node, were studied on a total of thirteen patients in neuroleptanaesthesia and during controlled hypotension with sodium nitroprusside (SNP). Invariably, the fall in blood pressure was associated with an increase in heart rate (20.0 +/- 4.3+; P less than 0.01), presumably due to an activation of the arterial baroreceptor reflex. Alinidine decreased heart rate to the original level but no fall in cardiac output occurred a ventricular stroke volume and the calculated left ventricular stroke work were increased compensatorily (35.9 +/- 7.2% and 35.9 +/- 6.7%, P less than 0.01, respectively). In patients who received alinidine before the onset of controlled hypotension (n = 5) SNP failed to elicit an increase in heart rate. It is concluded that in patients under neuroleptanaesthesia tachycardiac does not play an important role for the maintenance of an adequate cardiac output during controlled hypotension with SNP.
No takes yet. Share an insight, caveat, or question.
Zimpfer et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: